Work

Phase I/II study of nivolumab and ipilimumab combined with nintedanib in advanced NSCLC.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps9112

Authors: Sonam Puri, Sandrine Niyongere, Monica Sheila Chatwal, Theresa A. Boyle, Dung-Tsa Chen, David Noyes, Scott Joseph Antonia, Jhanelle Elaine Gray

Institution: Moffitt Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891480120

Cites:

Cited by: 3

Related to: 10